Molecule Details
| InChIKey | BTXNYTINYBABQR-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.99 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB13014 |
|---|---|
| Drug Name | Hypericin |
| CAS Number | 548-04-9 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Hypericin is under investigation for the treatment of Cutaneous T-cell Lymphoma. |
Categories: Anthracenes Anti-Infective Agents Antidepressive Agents Antineoplastic Agents Benz(a)Anthracenes Central Nervous System Agents Central Nervous System Depressants Enzyme Inhibitors Immunologic Factors Immunosuppressive Agents Phenalenes Psychotropic Drugs Radiation-Sensitizing Agents
Cross-references: BindingDB: 50060874 ChEBI: 5835 CHEMBL286494 ChemSpider: 4444511 C07606 PubChem:5281051 PubChem:347829150 RxCUI: 1546455 Wikipedia: Hypericin ZINC: ZINC000003780340